RNAi machinery regulates nutrient metabolism and fluconazole resistance in the pathogenic fungus Cryptococcus deneoformans

Med Mycol. 2023 Feb 3;61(2):myac095. doi: 10.1093/mmy/myac095.

Abstract

The RNAi machinery has been extensively studied in plant and animal cells for their crucial roles in the regulation of genome function. However, the potential roles of RNAi in controlling fungal growth and development have been poorly studied, especially in the basidiomycetous yeast Cryptococcus deneoformans. To characterize the biological functions of RNAi in the pathogenic fungus, a comparative analysis of mRNA profiles using high-throughput sequencing technology was performed for the wild type and the RNAi mutants of C. deneoformans. The results revealed a clear difference in the expression of genes associated with metabolic processes in the RNAi mutants. Besides, the growth under nutrient-limited conditions was significantly reduced in the ago2Δ mutant, suggesting the essential roles of Ago2 in nutrient metabolism. Further investigations revealed the differentially expressed transporters in the RNAi mutants, in which transporters involved in fluconazole efflux were significantly up-regulated. More importantly, on account of the upregulated transporters, RNAi mutant strains developed resistance to fluconazole. By disrupting AFR1 gene using the 'suicide' CRISPR-Cas9 system, we verified that the upregulated ABC transporter Afr1 in the RNAi mutants contributed to the fluconazole resistance. In summary, our data demonstrate that in C. deneoformans the RNAi pathway participates in nutrient metabolism and plays a role in the repression of fluconazole resistance, which provides a deep insight into RNAi mechanisms in Cryptococcus and brings great hints for the clinical treatment of cryptococcosis.

Keywords: Cryptococcus deneoformans; RNAi; fluconazole resistance; nutrient metabolism; transcriptome profiling.

Plain language summary

Transcriptome sequencing reveals biological functions of RNAi in C. deneoformans. Nutritional metabolism is deficient due to the AGO2 disruption. RNAi mechanism inhibits fluconazole resistance by regulating the expression of transporters.

MeSH terms

  • Animals
  • Antifungal Agents / therapeutic use
  • Cryptococcosis* / microbiology
  • Cryptococcosis* / veterinary
  • Cryptococcus neoformans* / genetics
  • Fluconazole / therapeutic use
  • Membrane Transport Proteins / genetics
  • RNA Interference

Substances

  • Fluconazole
  • Membrane Transport Proteins
  • Antifungal Agents